Kodu・Aktsiate loetelu・AngioDynamics Inc

AngioDynamics Inc

Avatud

SektorTervishoid

16.03 1.2

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

15.54

Max

16.02

Põhinäitajad
By Trading Economics
Sissetulek	-3.3M -11M
Müük	8.2M 87M
Aktsiakasum	-0.07
Kasumimarginaal	-13.169
Töötajad	632
EBITDA	-26M -28M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+32.49% upside

Dividendid
By Acuity
Järgmine tulemuste avaldamine	1. okt 2026

Turustatistika
By TradingEconomics
Turukapital	123M 652M
Eelmine avamishind	14.83
Eelmine sulgemishind	16.03

Uudiste sentiment

By Acuity

67%

33%

292 / 340 Pingereas Healthcare

AngioDynamics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. aug 2026, 20:08 UTC

AngioDynamics Inc shares are lower as the Health Care Equipment sub-sector declines. The overall market also closed lower during Wednesday's trading session.

24. aug 2026, 19:56 UTC

News

AngioDynamics Inc is lower today, continuing a trend of declines amid broader market pressures from recent geopolitical tensions affecting economic uncertainty.

18. aug 2026, 19:16 UTC

AngioDynamics Inc is trading higher, reaching a notable intraday high. The stock remains above its 20-day moving average amid a supportive market environment.

17. aug 2026, 19:41 UTC

AngioDynamics Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

13. aug 2026, 20:01 UTC

AngioDynamics Inc shares are lower today, reflecting a slight decline since Wednesday's close. The stock peaked earlier in the session before pulling back.

12. aug 2026, 22:02 UTC

AngioDynamics Inc shares are lower in after-market hours, with no specific news identified to explain the decline. They remain below their 20-day moving average.

11. aug 2026, 19:51 UTC

AngioDynamics Inc shares are higher today, driven by a significant upward trend in the Health Care Equipment sub-sector, remaining above the 20-day moving average.

10. aug 2026, 19:36 UTC

AngioDynamics Inc shares are higher since Friday's close, despite earlier declines. Broader market volatility may be influenced by fluctuations in oil prices.

7. aug 2026, 19:33 UTC

News

AngioDynamics shares are rising despite a downgrade to Q3 2028 earnings estimates. Analysts from Canaccord Genuity and HC Wainwright raised their price targets.

6. aug 2026, 19:56 UTC

AngioDynamics shares are lower during Thursday's session, with no specific news identified. The stock remains above its 20-day moving average.

5. aug 2026, 19:46 UTC

AngioDynamics Inc shares are lower amid broader market caution following ADP's report of only 44,000 private sector jobs added in July.

4. aug 2026, 19:31 UTC

AngioDynamics Inc shares are lower today, driven by significant declines in the Health Care Equipment sub-sector. No specific company news was identified.

3. aug 2026, 20:02 UTC

AngioDynamics Inc shares are higher today, supported by gains in the Health Care Equipment sector. The stock remains above its 20-day moving average.

31. juuli 2026, 19:33 UTC

AngioDynamics shares are lower amid broader market dynamics and rising bond yields, despite remaining above the 20-day moving average.

30. juuli 2026, 18:56 UTC

AngioDynamics Inc. shares are trading roughly flat, remaining above their 20-day moving average after four consecutive sessions of higher closes.

29. juuli 2026, 19:56 UTC

Macro Event

AngioDynamics Inc shares are higher since Tuesday, reflecting volatility from the Federal Reserve's interest rate decision and easing inflation data.

28. juuli 2026, 20:02 UTC

News

AngioDynamics will participate in two investor conferences this week, contributing to a notable increase in shares during Tuesday's session.

27. juuli 2026, 19:56 UTC

AngioDynamics Inc is rising amid strength in the health care equipment sector. The stock reached a peak earlier in the session before moderating gains.

24. juuli 2026, 18:36 UTC

AngioDynamics Inc is trading higher today, reflecting a positive market response. The stock remains above its 20-day moving average amid no specific news.

23. juuli 2026, 20:03 UTC

AngioDynamics Inc. shares are lower today, reflecting a decline from Wednesday's close amid broader market weakness in tech stocks related to rising AI capital expenditures.

22. juuli 2026, 19:56 UTC

AngioDynamics Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. The stock remains above its 20-day moving average.

21. juuli 2026, 20:06 UTC

News

AngioDynamics Inc shares are higher today, supported by a strong Nasdaq 100 Index. Analysts maintain a Hold rating amid optimism for NanoKnife technology.

20. juuli 2026, 19:46 UTC

News

AngioDynamics shares are higher today, despite a downgrade to "strong sell" from Zacks Research and a price target increase from Canaccord Genuity to $20.00.

Võrdlus sarnastega

Hinnamuutus

AngioDynamics Inc Prognoos

Hinnasiht

By TipRanks

32.49% tõus

12 kuu keskmine prognoos

Keskmine 21 USD 32.49%

Kõrge 24 USD

Madal 19 USD

Põhineb 3 Wall Streeti analüütiku instrumendi AngioDynamics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi AngioDynamics Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

292 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.